Literature DB >> 28527754

Hippo signalling in intestinal regeneration and cancer.

Alex Gregorieff1, Jeffrey L Wrana2.   

Abstract

The Hippo pathway is a unique signalling module that regulates cell-specific transcriptional responses and responds to a wide range of intrinsic and extrinsic cues. Besides its classical role in restricting tissue size during development, Hippo signalling is now recognized to control numerous processes including cell proliferation, survival, cell fate determination, epithelial-to-mesenchymal transitions and cell migration. Because of its highly dynamic nature, the intestinal epithelium has served as an exceptional model to study the complex roles of Hippo signalling. In this review, we shall present an overview of Hippo function in the mammalian intestine and discuss the various mechanisms regulating Hippo signalling and how they contribute to intestinal regeneration and cancer.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28527754     DOI: 10.1016/j.ceb.2017.04.005

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  15 in total

1.  SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients.

Authors:  Chuanjia Yang; Weixue Xu; Xiangzhen Meng; Siqi Zhou; Minglu Zhang; Dongxu Cui
Journal:  J Histochem Cytochem       Date:  2018-09-14       Impact factor: 2.479

Review 2.  Cell fate specification and differentiation in the adult mammalian intestine.

Authors:  Joep Beumer; Hans Clevers
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09-21       Impact factor: 94.444

3.  Helminth-induced reprogramming of the stem cell compartment inhibits type 2 immunity.

Authors:  Danielle Karo-Atar; Shaida Ouladan; Tanvi Javkar; Loick Joumier; Macy K Matheson; Sydney Merritt; Susan Westfall; Annie Rochette; Maria E Gentile; Ghislaine Fontes; Gregory J Fonseca; Marc Parisien; Luda Diatchenko; Jakob von Moltke; Mohan Malleshaiah; Alex Gregorieff; Irah L King
Journal:  J Exp Med       Date:  2022-08-08       Impact factor: 17.579

4.  Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription.

Authors:  Qi Li; Yang Sun; Gopala K Jarugumilli; Shun Liu; Kyvan Dang; Jennifer L Cotton; Jordi Xiol; Pui Yee Chan; Michael DeRan; Lifang Ma; Rui Li; Lihua J Zhu; Joyce H Li; Andrew B Leiter; Y Tony Ip; Fernando D Camargo; Xuelian Luo; Randy L Johnson; Xu Wu; Junhao Mao
Journal:  Cell Stem Cell       Date:  2020-04-06       Impact factor: 24.633

Review 5.  Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway.

Authors:  Kevin I Watt; Kieran F Harvey; Paul Gregorevic
Journal:  Front Physiol       Date:  2017-11-24       Impact factor: 4.566

6.  Yap-lin28a axis targets let7-Wnt pathway to restore progenitors for initiating regeneration.

Authors:  Zhian Ye; Zhongwu Su; Siyu Xie; Yuye Liu; Yongqiang Wang; Xi Xu; Yiqing Zheng; Meng Zhao; Linjia Jiang
Journal:  Elife       Date:  2020-04-30       Impact factor: 8.140

7.  HNF4α and CDX2 Regulate Intestinal YAP1 Promoter Activity.

Authors:  Sylvester Larsen; Johanne Davidsen; Katja Dahlgaard; Ole B Pedersen; Jesper T Troelsen
Journal:  Int J Mol Sci       Date:  2019-06-18       Impact factor: 5.923

8.  The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth.

Authors:  Sarah Morice; Mathilde Mullard; Regis Brion; Maryne Dupuy; Sarah Renault; Robel Tesfaye; Bénédicte Brounais-Le Royer; Benjamin Ory; Françoise Redini; Franck Verrecchia
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.639

9.  Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration.

Authors:  Oriane Guillermin; Nikolaos Angelis; Clara M Sidor; Rachel Ridgway; Anna Baulies; Anna Kucharska; Pedro Antas; Melissa R Rose; Julia Cordero; Owen Sansom; Vivian S W Li; Barry J Thompson
Journal:  EMBO J       Date:  2021-05-05       Impact factor: 14.012

10.  Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas.

Authors:  Yuan Gu; Yu Wang; Yebin Wang; Jiaqian Luo; Xin Wang; Mingyue Ma; Wei Hua; Ying Liu; Fa-Xing Yu
Journal:  Front Cell Dev Biol       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.